tiprankstipranks
Advertisement
Advertisement

ZURA Stock Latest News

Zura Bio management to meet with Piper Sandler
The FlyZura Bio management to meet with Piper Sandler
18d ago
ZURA
Zura Bio price target lowered to $15 from $16 at Oppenheimer
PremiumThe Fly
Zura Bio price target lowered to $15 from $16 at Oppenheimer
22d ago
ZURA
Zura Bio Reports 2025 Results, Extends Cash Runway Outlook
PremiumCompany Announcements
Zura Bio Reports 2025 Results, Extends Cash Runway Outlook
22d ago
8K
ZURA
Zura Bio reports FY25 EPS ($1.06) vs (60c) last year
PremiumThe Fly
Zura Bio reports FY25 EPS ($1.06) vs (60c) last year
22d ago
ZURA
Zura Bio Updates Corporate Outlook on Lead Tibulizumab Program
PremiumCompany Announcements
Zura Bio Updates Corporate Outlook on Lead Tibulizumab Program
1M ago
8K
ZURA
Zura Bio Highlights TibuSURE Phase 2 Trial Design
PremiumCompany AnnouncementsZura Bio Highlights TibuSURE Phase 2 Trial Design
1M ago
8K
ZURA
Zura Bio Raises Capital Through Expanded Equity Offering
Premium
Company Announcements
Zura Bio Raises Capital Through Expanded Equity Offering
1M ago
8K
ZURA
Zura Bio 18.2M share Spot Secondary priced at $6.25
Premium
The Fly
Zura Bio 18.2M share Spot Secondary priced at $6.25
1M ago
ZURA
Zura Bio announces common stock offering, amount not stated
PremiumThe Fly
Zura Bio announces common stock offering, amount not stated
2M ago
ZURA
Zura Bio spot secondary offering; price range $6.00-$6.25
PremiumThe Fly
Zura Bio spot secondary offering; price range $6.00-$6.25
2M ago
ZURA
Zura Bio Strengthens Board with Immunology and R&D Leaders
PremiumCompany Announcements
Zura Bio Strengthens Board with Immunology and R&D Leaders
2M ago
8K
ZURA
Zura Bio management to meet with Piper Sandler
PremiumThe Fly
Zura Bio management to meet with Piper Sandler
2M ago
ZURA
Zura Bio Advances Tibulizumab Strategy in Autoimmune Diseases
PremiumCompany AnnouncementsZura Bio Advances Tibulizumab Strategy in Autoimmune Diseases
2M ago
8K
ZURA
Wedbush bullish on Zura Bio, initiates with an Outperform
Premium
The Fly
Wedbush bullish on Zura Bio, initiates with an Outperform
2M ago
ZURA
Zura Bio initiated with an Outperform at Wedbush
Premium
The Fly
Zura Bio initiated with an Outperform at Wedbush
2M ago
ZURA
Zura Bio CEO Robert Lisicki resigns, Sandeep Kulkarni succeeds
PremiumThe Fly
Zura Bio CEO Robert Lisicki resigns, Sandeep Kulkarni succeeds
3M ago
ZURA
Zura Bio Updates Outlook and Clinical Development Plans
PremiumCompany Announcements
Zura Bio Updates Outlook and Clinical Development Plans
3M ago
8K
ZURA
Zura Bio provides business updates, 2026 outlook
PremiumThe Fly
Zura Bio provides business updates, 2026 outlook
3M ago
ZURA
Zura Bio resets key agreements after internal review
PremiumCompany Announcements
Zura Bio resets key agreements after internal review
3M ago
8K
ZURA
Zura Bio Director Resignation Sparks Governance Adjustments
PremiumCompany AnnouncementsZura Bio Director Resignation Sparks Governance Adjustments
4M ago
8K
ZURA
Zura Bio Limited Reports Third Quarter 2025 Results
Premium
Company Announcements
Zura Bio Limited Reports Third Quarter 2025 Results
5M ago
ZURA
Zura Bio reports Q3 EPS (21c), consensus (18c)
Premium
The Fly
Zura Bio reports Q3 EPS (21c), consensus (18c)
5M ago
ZURA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >